Read, Learn, Innovate: Top Blog Posts from October 2019
Featured in this edition of iSpeak Reading Roundup, are the top blog posts from October 2019. See leading facilities, break-through therapies, innovative technologies, and more for what the pharmaceutical industry was reading in October.
Learn more about how modular and podular construction designs can shape facilities of biopharmaceutical manufacturing. These facility designs can have the ability to address the severity of natural disasters and the impact on vulnerable populations globally.
This year’s category winner proved excellence in the incorporation of novel technologies, improved efficiencies, and success in eliminating challenges. Read more about Pfizer’s first modular biological production facility!
See the updates and new changes to EU Clinical Trial Regulation, including a single approach for the application and maintenance of the CT authorisation and this applies to trials whether they are multi-member state or mono-state.
Review current challenges validation experts are facing when implementing programs for advanced manufacturing. Key ideas addressed are continuous validation techniques and multi-step production challenges.
Discover how AveXis overcame challenges in execution and delivery of novel treatments for patients affected by rare and life-threatening neurological genetic diseases. The company received an Honorable Mention Award for this year’s competition.
Pharmaceutical Engineering is introducing a new part of the Pharmaceutical Engineering Online site: Online Exclusives. This content will be published only to the ISPE web site—it will not be published in print. Read on for FAQs about this new feature,...
Featured in this edition of iSpeak Reading Roundup, are the top blog posts from February 2020. Discover key insights for cleaning validation practices, risk-based approaches to quality, and more for what the pharmaceutical industry was reading last...
As we continue to monitor the COVID-19 pandemic, our thoughts are with our Members and those impacted. We recognize that the ever-changing impact of this novel virus is disruptive to so many aspects of our personal and professional lives. We are not...